All In Biotech

Drug Trial Radar · NCT00304070

Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor

Treatment of Adrenocortical Tumors With Surgery Plus Lymph Node Dissection and Multiagent Chemotherapy: A Groupwide Phase III Study

Last checked: Nov 20, 2026Latest source record: Feb 28, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

78

Actual

Start

May 3, 2007

Primary completion

Dec 31, 2015

Study completion Jun 30, 2023

Sponsor

Lead sponsor
Children's Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Mar 17, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III clinical trial is studying how well cisplatin-based chemotherapy and/or surgery works in treating young patients with stage I, stage II, stage III or stage IV adrenocortical cancer. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Giving chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving it after surgery may kill any tumor cells that remain after surgery.

Conditions

  • Stage I Adrenal Cortical Carcinoma AJCC v7
  • Stage II Adrenal Cortical Carcinoma AJCC v7
  • Stage III Adrenal Cortical Carcinoma AJCC v7
  • Stage IV Adrenal Cortical Carcinoma AJCC v7

Interventions

  • CisplatinDrug

    Given IV

  • Conventional SurgeryProcedure

    Patients undergo surgery

  • Doxorubicin HydrochlorideDrug

    Given IV

  • EtoposideDrug

    Given IV

  • FilgrastimBiological

    Given subcutaneously

  • MitotaneDrug

    Given orally

  • PegfilgrastimBiological

    Given subcutaneously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Five Year Event-free Survival (EFS)Time frame: Up to five years after enrollment

Locations

91 sites in 4 countries. Site status is shown where the registry gives one.

  • Children's Hospital of Alabama

    Birmingham, Alabama

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama

  • Banner University Medical Center - Tucson

    Tucson, Arizona

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Kaiser Permanente Downey Medical Center

    Downey, California

  • Miller Children's and Women's Hospital Long Beach

    Long Beach, California

  • Children's Hospital Los Angeles

    Los Angeles, California

  • Valley Children's Hospital

    Madera, California

  • Children's Hospital of Orange County

    Orange, California

  • Lucile Packard Children's Hospital Stanford University

    Palo Alto, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center

    Denver, Colorado

  • University of Connecticut

    Farmington, Connecticut

  • Connecticut Children's Medical Center

    Hartford, Connecticut

  • Alfred I duPont Hospital for Children

    Wilmington, Delaware

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • Lee Memorial Health System

    Fort Myers, Florida

  • Nemours Children's Clinic-Jacksonville

    Jacksonville, Florida

  • University of Miami Miller School of Medicine-Sylvester Cancer Center

    Miami, Florida

  • Nemours Children's Clinic - Orlando

    Orlando, Florida

  • Nemours Children's Clinic - Pensacola

    Pensacola, Florida

  • Sacred Heart Hospital

    Pensacola, Florida

  • Johns Hopkins All Children's Hospital

    St. Petersburg, Florida

  • Saint Joseph's Hospital/Children's Hospital-Tampa

    Tampa, Florida

  • Saint Mary's Hospital

    West Palm Beach, Florida

  • Tripler Army Medical Center

    Honolulu, Hawaii

  • Lurie Children's Hospital-Chicago

    Chicago, Illinois

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois

  • Saint Jude Midwest Affiliate

    Peoria, Illinois

  • Southern Illinois University School of Medicine

    Springfield, Illinois

  • Indiana University/Melvin and Bren Simon Cancer Center

    Indianapolis, Indiana

  • Riley Hospital for Children

    Indianapolis, Indiana

  • University of Kentucky/Markey Cancer Center

    Lexington, Kentucky

  • Norton Children's Hospital

    Louisville, Kentucky

  • Tulane University Health Sciences Center

    New Orleans, Louisiana

  • Sinai Hospital of Baltimore

    Baltimore, Maryland

  • Walter Reed National Military Medical Center

    Bethesda, Maryland

  • Dana-Farber Cancer Institute

    Boston, Massachusetts

  • Wayne State University/Karmanos Cancer Institute

    Detroit, Michigan

  • Michigan State University Clinical Center

    East Lansing, Michigan

Showing 40 of 91 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.